000 | 01388 a2200421 4500 | ||
---|---|---|---|
005 | 20250514211430.0 | ||
264 | 0 | _c20050414 | |
008 | 200504s 0 0 eng d | ||
022 | _a0012-1797 | ||
024 | 7 |
_a10.2337/diabetes.53.suppl_3.s63 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFarret, A | |
245 | 0 | 0 |
_aP2Y purinergic potentiation of glucose-induced insulin secretion and pancreatic beta-cell metabolism. _h[electronic resource] |
260 |
_bDiabetes _cDec 2004 |
||
300 |
_aS63-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenosine Diphosphate _xanalogs & derivatives |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDiazoxide _xpharmacology |
650 | 0 | 4 |
_aGlucose _xpharmacology |
650 | 0 | 4 |
_aInsulin _xmetabolism |
650 | 0 | 4 | _aInsulin Secretion |
650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNitroprusside _xpharmacology |
650 | 0 | 4 |
_aPotassium Channels _xphysiology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReceptors, Purinergic P1 _xphysiology |
650 | 0 | 4 |
_aThionucleotides _xpharmacology |
700 | 1 | _aVignaud, M | |
700 | 1 | _aDietz, S | |
700 | 1 | _aVignon, J | |
700 | 1 | _aPetit, P | |
700 | 1 | _aGross, R | |
773 | 0 |
_tDiabetes _gvol. 53 Suppl 3 _gp. S63-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2337/diabetes.53.suppl_3.s63 _zAvailable from publisher's website |
999 |
_c15247773 _d15247773 |